Meng‐Li Cheng

机构：Capital Medical University, Beijing Chest Hospital, Beijing Children’s Hospital · ORCID：0009-0003-1723-2764

发表论文 37 篇 · 总被引 2469 次 · h-index 15

代表论文

• The m6A methylome of SARS-CoV-2 in host cells (2021 · Cell Research · 被引 175)
• Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates (2021 · Signal Transduction and Targeted Therapy · 被引 63)
• Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients (2021 · Frontiers in Immunology · 被引 50)
• Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling study (2023 · EClinicalMedicine · 被引 24)
• Proteome-wide epitope mapping identifies a resource of antibodies for SARS-CoV-2 detection and neutralization (2021 · Signal Transduction and Targeted Therapy · 被引 21)
• In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria (2022 · Microbiology Spectrum · 被引 20)